PortfoliosLab logo
Zoetis Inc. (ZTS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US98978V1035

CUSIP

98978V103

IPO Date

Feb 1, 2013

Highlights

Market Cap

$68.50B

EPS (TTM)

$5.46

PE Ratio

28.13

PEG Ratio

2.76

Total Revenue (TTM)

$7.07B

Gross Profit (TTM)

$4.96B

EBITDA (TTM)

$3.00B

Year Range

$139.22 - $198.58

Target Price

$195.49

Short %

1.74%

Short Ratio

2.90

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Zoetis Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%December2025FebruaryMarchAprilMay
457.75%
275.81%
ZTS (Zoetis Inc.)
Benchmark (^GSPC)

Returns By Period

Zoetis Inc. (ZTS) returned -2.75% year-to-date (YTD) and -4.80% over the past 12 months. Over the past 10 years, ZTS delivered an annualized return of 14.06%, outperforming the S&P 500 benchmark at 10.56%.


ZTS

YTD

-2.75%

1M

-3.38%

6M

-12.91%

1Y

-4.80%

5Y*

5.17%

10Y*

14.06%

^GSPC (Benchmark)

YTD

-3.31%

1M

0.28%

6M

-0.74%

1Y

12.29%

5Y*

15.01%

10Y*

10.56%

*Annualized

Monthly Returns

The table below presents the monthly returns of ZTS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.21%-2.14%-1.55%-4.69%0.66%-2.75%
2024-4.63%5.60%-14.68%-5.62%6.48%2.24%4.10%1.92%6.48%-8.28%-1.97%-7.03%-16.63%
202313.19%0.91%-0.34%5.84%-7.26%5.64%9.46%1.29%-8.68%-9.54%12.53%11.72%35.91%
2022-18.00%-3.07%-2.61%-5.85%-3.57%0.56%6.40%-14.25%-5.26%1.90%2.23%-4.92%-39.51%
2021-6.65%0.64%1.44%10.04%2.11%5.48%8.91%0.92%-5.09%11.50%2.70%9.90%48.26%
20201.55%-0.73%-11.66%10.05%7.80%-1.69%10.84%5.55%3.29%-4.00%1.15%3.19%25.76%
20190.92%9.37%6.83%1.33%-0.78%12.31%1.38%10.04%-1.45%2.80%-5.78%9.82%55.71%
20186.69%5.38%3.28%0.11%0.26%1.78%1.66%4.76%1.06%-1.54%4.27%-8.87%19.45%
20172.84%-2.97%0.11%5.34%11.00%0.33%0.22%0.29%1.69%0.09%13.45%-0.35%35.55%
2016-9.97%-4.62%7.96%6.31%0.83%0.29%6.34%1.25%1.78%-8.09%5.61%6.25%12.64%
2015-0.51%7.86%0.43%-3.87%12.04%-3.11%1.58%-8.23%-8.22%4.44%8.78%2.61%12.18%
2014-6.91%2.17%-6.71%4.82%1.45%5.11%1.98%7.92%4.26%0.57%21.14%-4.23%32.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ZTS is 48, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ZTS is 4848
Overall Rank
The Sharpe Ratio Rank of ZTS is 5151
Sharpe Ratio Rank
The Sortino Ratio Rank of ZTS is 4242
Sortino Ratio Rank
The Omega Ratio Rank of ZTS is 4242
Omega Ratio Rank
The Calmar Ratio Rank of ZTS is 5252
Calmar Ratio Rank
The Martin Ratio Rank of ZTS is 5151
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Zoetis Inc. (ZTS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for ZTS, currently valued at -0.00, compared to the broader market-2.00-1.000.001.002.003.00
ZTS: -0.00
^GSPC: 0.67
The chart of Sortino ratio for ZTS, currently valued at 0.17, compared to the broader market-6.00-4.00-2.000.002.004.00
ZTS: 0.17
^GSPC: 1.05
The chart of Omega ratio for ZTS, currently valued at 1.02, compared to the broader market0.501.001.502.00
ZTS: 1.02
^GSPC: 1.16
The chart of Calmar ratio for ZTS, currently valued at -0.00, compared to the broader market0.001.002.003.004.005.00
ZTS: -0.00
^GSPC: 0.68
The chart of Martin ratio for ZTS, currently valued at -0.00, compared to the broader market-10.000.0010.0020.00
ZTS: -0.00
^GSPC: 2.70

The current Zoetis Inc. Sharpe ratio is -0.00. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Zoetis Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.00
0.67
ZTS (Zoetis Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Zoetis Inc. provided a 1.18% dividend yield over the last twelve months, with an annual payout of $1.86 per share. The company has been increasing its dividends for 11 consecutive years.


0.40%0.50%0.60%0.70%0.80%0.90%1.00%1.10%$0.00$0.50$1.00$1.5020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$1.86$1.73$1.50$1.30$1.00$0.80$0.66$0.50$0.42$0.38$0.33$0.29

Dividend yield

1.18%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%0.67%

Monthly Dividends

The table displays the monthly dividend distributions for Zoetis Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.50$0.00$0.00$0.50$0.00$1.00
2024$0.43$0.00$0.00$0.43$0.00$0.00$0.43$0.00$0.00$0.43$0.00$0.00$1.73
2023$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00$1.50
2022$0.33$0.00$0.00$0.33$0.00$0.00$0.33$0.00$0.00$0.33$0.00$0.00$1.30
2021$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$1.00
2020$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.20$0.00$0.00$0.80
2019$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.66
2018$0.13$0.00$0.00$0.13$0.00$0.00$0.13$0.00$0.00$0.00$0.13$0.00$0.50
2017$0.11$0.00$0.00$0.11$0.00$0.11$0.00$0.00$0.00$0.00$0.11$0.00$0.42
2016$0.10$0.00$0.00$0.10$0.00$0.10$0.00$0.00$0.00$0.00$0.10$0.00$0.38
2015$0.08$0.00$0.00$0.08$0.00$0.00$0.00$0.08$0.00$0.00$0.08$0.00$0.33
2014$0.07$0.00$0.00$0.07$0.00$0.00$0.00$0.07$0.00$0.00$0.07$0.00$0.29

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%
ZTS: 1.2%
Zoetis Inc. has a dividend yield of 1.18%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%
ZTS: 31.5%
Zoetis Inc. has a payout ratio of 31.49%, which is quite average when compared to the overall market. This suggests that Zoetis Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-34.15%
-7.45%
ZTS (Zoetis Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Zoetis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zoetis Inc. was 46.52%, occurring on Nov 3, 2022. The portfolio has not yet recovered.

The current Zoetis Inc. drawdown is 34.15%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.52%Dec 30, 2021214Nov 3, 2022
-36.07%Feb 14, 202026Mar 23, 202081Jul 17, 2020107
-28.57%Jun 26, 2015158Feb 10, 2016243Jan 27, 2017401
-17.32%Mar 15, 2013272Apr 11, 201489Aug 19, 2014361
-17.28%Nov 5, 202081Mar 4, 202139Apr 29, 2021120

Volatility

Volatility Chart

The current Zoetis Inc. volatility is 11.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2025FebruaryMarchAprilMay
11.24%
14.17%
ZTS (Zoetis Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zoetis Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Zoetis Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 4.7% positive surprise.

0.600.801.001.201.401.60AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
1.40
1.34
Actual
Estimate

Valuation

The Valuation section provides an overview of how Zoetis Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
ZTS: 28.1
The chart displays the Price-to-Earnings (P/E) ratio for ZTS, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/E ratio of 28.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
ZTS: 2.8
The chart shows the Price/Earnings to Growth (PEG) ratio for ZTS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. ZTS currently has a PEG ratio of 2.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
2.04.06.08.010.0
ZTS: 7.5
This chart shows the Price-to-Sales (P/S) ratio for ZTS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/S ratio of 7.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
2.04.06.08.010.0
ZTS: 14.6
The chart illustrates the Price-to-Book (P/B) ratio for ZTS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/B value of 14.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items